Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02090491 · ClinicalTrials.gov registry record
MENTIS Personal Health Record Rapid Pilot Research Deployment and Evaluation
A clinical trial of Autism, sponsored by Northeastern University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT02090491 is a study of Autism that has completed, run by Northeastern University. The registered enrollment target is 20 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02090491, a study of Autism, has completed, sponsored by Northeastern University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Autism Spectrum Disorder (ASD) is a collection of complex neurodevelopmental disorders characterized by qualitative impairments in socialization, communication, and circumscribed interests, including stereotypical behavior patterns and behavioral rigidity to changes in routines (American Psychiatric Association, 1994). ASD is the fastest growing pervasive developmental disorder of childhood, currently estimated to affect 1 in 88 school age children (Baio, 2012). ASD typically manifests in infancy and persist throughout the lifespan. There is no known cause or cure for ASD, yet structured behavioral interventions and medications can enhance developmental outcomes. ASD has a profound impact on families and often result in enormous emotional and financial costs. Recent estimates suggest that societal costs in the US to care for all individuals diagnosed each year over their lifetime approaches $35 billion (Ganz, 2007). Janssen Research \& Development is building a comprehensive digital platform (MENTIS) to optimize and enhance development of novel medicines and track outcomes in individuals with ASD. The MENTIS platform contains several core components, including: (1) An electronic personal healthcare record, designed specifically for individuals with ASD and their caregivers (parents, teachers, healthcare providers); (2) Integrated physiological and physical activity biosensors designed to objectively assess outcomes important in ASD, and; (3) A de-identified research data warehouse with analytic tools to better measure outcomes, assist with sub-population identification, and identify algorithms for diagnosis and treatment response detection. The MENTIS platform is currently being designed, developed, and prepared for testing. During this process it is highly desirable to conduct feasibility and usability research with a sample of the target population to identify important system components and features, optimize design, and reduce redundancy in software developmen
Conditions Studied
Study Locations (1)
New York
- Center for Discovery - Harris
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02090491
The ClinicalTrials.gov registry entry for NCT02090491 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (89% lower). The listed sponsor is Northeastern University, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 0 interventions.
NCT02090491 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02090491 about?
NCT02090491 is a clinical study titled "MENTIS Personal Health Record Rapid Pilot Research Deployment and Evaluation". Autism Spectrum Disorder (ASD) is a collection of complex neurodevelopmental disorders characterized by qualitative impairments in socialization, communication, and circumscribed interests, including stereotypical behavior patterns and behavioral rigidity to changes in routines (American Psychiatric...
What is the current status of trial NCT02090491?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2013-11. Estimated completion is 2014-10.
What conditions does trial NCT02090491 study?
This clinical trial studies the following conditions: Autism.
Who is sponsoring clinical trial NCT02090491?
This trial is sponsored by Northeastern University, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02090491 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
-
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
RECRUITING · NA
-
Optimizing Outcomes for Young Autistic Children
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.